Personen
Prof. Dr. med. Albrecht Stenzinger
Prof. Dr. med. Albrecht Stenzinger

Stellv. Ärztlicher Direktor (Allgemeine Pathologie und Pathologische Anatomie)

Leiter Molekularpathologisches Zentrum


06221 56-34380

Ärztlicher / Beruflicher Werdegang

seit Dezember 2019

Deputy Director, Institute of Pathology, Heidelberg (IPH), Germany

seit Oktober 2018

Professor of Molecular Tumor Pathology, Ruprecht-Karls-University Heidelberg, Germany          

seit Juni 2016

Head, Center for Molecular Pathology (CMP) of the Institute of Pathology (IPH), and Section Head Molecular Pathology and Biomarker Development, University Hospital Heidelberg, Germany

seit Juni 2016

Senior Consultant Pathologist, Institute of Pathology (IPH), University Hospital Heidelberg, Germany

seit 2015

Board Exam in Pathology

2010 – 2015

Residency in Pathology, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

2009 – 2010

Residency in Pathology, Institute of Pathology, Charité University Hospital, Berlin, Germany

Wissenschaftlicher Werdegang

2015 – 2016

Senior Research Fellow, Massachusetts General Hospital, Harvard Medical School, Boston, USA

seit 2015

Fellow of the Heidelberg School of Oncology (HSO) at the National Center for Tumor Diseases (NCT), Heidelberg, Germany

2011 – 2013

PostDoc, Institute of Pathology, University Hospital Heidelberg, Heidelberg, Germany

seit 2009

Justus-Liebig University Giessen Faculty of Medicine, Germany Doctoral thesis (Dr.med.): summa cum laude

                                   

seit 2008

Justus-Liebig University Giessen Medical School, Germany M.D. degree

                                   

2007 – 2008

Internship: Dept. of Visceral-, Transplant- and Thoracic Surgery and Dept. of Trauma Surgery, Justus Liebig University Giessen Medical School, Germany Institute of Pathology, St. Gallen, Switzerland Dept. of Internal Medicine, University Hopital Basel, Switzerland

                       

seit 2006

MD Anderson Cancer Center (MDACC), Houston, Texas, USA

seit 2006

University Medical Center Groningen, NL

seit 2005

Queen’s University Belfast Medical School, UK

2002 – 2008

Justus-Liebig University Giessen Medical School, Germany

Auszeichnungen

seit 2019

Proffered Paper, selected abstract ESMO-IO

seit 2019

Visiting Professor, University of Belgrade, Serbia

seit 2018

ISLAC Asia 2018, Best Abstract Award

Januar 2011 – Dezember 2015

Heidelberg School of Oncology (HSO) Fellowship

seit 2013

EACR Meeting Award “3rd EACR-EOCI Joint Training Course: Molecular Pathology Approach to Cancer”

seit 2012

Award, Pathologist-in-Training Academy of the German Society of Pathology (DGP), Germany

Juli 2011 – Juli 2013

Postdoc-Grant (Young Investigator Award) of the Medical Faculty of the University Heidelberg

Mitgliedschaften

American Association for Cancer Research (AACR)

Association for Molecular Pathology (AMP)

Arbeitsgemeinschaft Internistische Onkologie (AIO)

American Society of Clincial Oncology (ASCO)

Deutsche Gesellschaft für Pathologie (DGP)

Deutsche Krebsgesellschaft (DKH)

The European Association for Cancer Research (EACR)

European Society for Medical Oncology (ESMO)

Ämter und Funktionen

seit 2019

Principal Investigator, German Center for Lung Research (DZL)

seit 2019

Speaker, Working Group Diagnostics, Zentren für Personalisierte Medizin (ZPM), Baden-Wurttemberg, Germany

seit 2019

Member, Scientific Advisory Board, Genomic Medicine Sweden (GMS)

seit 2018

Member, Working Groups Genomics and Pathology, Cancer Core Europe

seit 2015

Co-Investigator and Member Scientific Board, MASTER-Program, NCT Heidelberg, Germany
                                   

Fields of Interest

Tumor genetics
Immuno-Oncology
Drug targets
Predictive biomarkers
Complex biomarkers
Lung cancer

Editorial Boards

seit 2020

Rubrikherausgeber ‘Molekulares Tumorboard’, der Pathologe

seit 2020

Associate Editor, Genes Chromosomes Cancer

seit 2019

Editoral Board, Translational Lung Cancer Research